DPACE regimen
Term · Oncology and biomedicine · MLC-T-ONC-013164
A regimen consisting of dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide that may be used as a salvage regimen for aggressive and/or refractory plasma cell myeloma.
| Identifier | MLC-T-ONC-013164 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | D-PACE |
| Synonyms | cisplatin/cyclophosphamide/dexamethasone/doxorubicin/etoposide; cisplatin/cyclophosphamide/dexamethasone/doxorubicin/etoposide regimen; decadron/platinol/adriamycin/cytoxan/etoposide regimen; dexamethasone-cisplatin-doxorubicin-cyclophosphamide-etoposide regimen; dexamethasone/cisplatin/doxorubicin/cyclophosphamide/etoposide; dexamethasone/cisplatin/doxorubicin/cyclophosphamide/etoposide regimen |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013164",
"term": "DPACE regimen",
"field": "Oncology and biomedicine",
"definition": "A regimen consisting of dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide that may be used as a salvage regimen for aggressive and/or refractory plasma cell myeloma.",
"abbreviation": "D-PACE",
"synonyms": [
"cisplatin/cyclophosphamide/dexamethasone/doxorubicin/etoposide",
"cisplatin/cyclophosphamide/dexamethasone/doxorubicin/etoposide regimen",
"decadron/platinol/adriamycin/cytoxan/etoposide regimen",
"dexamethasone-cisplatin-doxorubicin-cyclophosphamide-etoposide regimen",
"dexamethasone/cisplatin/doxorubicin/cyclophosphamide/etoposide",
"dexamethasone/cisplatin/doxorubicin/cyclophosphamide/etoposide regimen"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/dpace-regimen/"
}
Record 6,230 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.